These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 33820711

  • 21. Effects of concomitant neuromuscular electrical stimulation during repetitive transcranial magnetic stimulation before repetitive facilitation exercise on the hemiparetic hand.
    Etoh S, Kawamura K, Tomonaga K, Miura S, Harada S, Noma T, Kikuno S, Ueno M, Miyata R, Shimodozono M.
    NeuroRehabilitation; 2019; 45(3):323-329. PubMed ID: 31796693
    [Abstract] [Full Text] [Related]

  • 22. Effect of baseline spastic hemiparesis on recovery of upper-limb function following botulinum toxin type A injections and postinjection therapy.
    Chang CL, Munin MC, Skidmore ER, Niyonkuru C, Huber LM, Weber DJ.
    Arch Phys Med Rehabil; 2009 Sep; 90(9):1462-8. PubMed ID: 19735772
    [Abstract] [Full Text] [Related]

  • 23. Neuronox versus BOTOX in the Treatment of Post-Stroke Upper Limb Spasticity: A Multicenter Randomized Controlled Trial.
    Seo HG, Paik NJ, Lee SU, Oh BM, Chun MH, Kwon BS, Bang MS.
    PLoS One; 2015 Sep; 10(6):e0128633. PubMed ID: 26030192
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Botulinum toxin a, evidence-based exercise therapy, and constraint-induced movement therapy for upper-limb hemiparesis attributable to stroke: a preliminary study.
    Levy CE, Giuffrida C, Richards L, Wu S, Davis S, Nadeau SE.
    Am J Phys Med Rehabil; 2007 Sep; 86(9):696-706. PubMed ID: 17709993
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Efficacy and Safety of MT10107 (Coretox) in Poststroke Upper Limb Spasticity Treatment: A Randomized, Double-Blind, Active Drug-Controlled, Multicenter, Phase III Clinical Trial.
    Lee J, Chun MH, Ko YJ, Lee SU, Kim DY, Paik NJ, Kwon BS, Park YG.
    Arch Phys Med Rehabil; 2020 Sep; 101(9):1485-1496. PubMed ID: 32497599
    [Abstract] [Full Text] [Related]

  • 30. Combined therapy using botulinum toxin A and single-joint hybrid assistive limb for upper-limb disability due to spastic hemiplegia.
    Saita K, Morishita T, Hyakutake K, Fukuda H, Shiota E, Sankai Y, Inoue T.
    J Neurol Sci; 2017 Feb 15; 373():182-187. PubMed ID: 28131185
    [Abstract] [Full Text] [Related]

  • 31. The Effects of Botulinum Toxin Injections on Spasticity and Motor Performance in Chronic Stroke with Spastic Hemiplegia.
    Chen YT, Zhang C, Liu Y, Magat E, Verduzco-Gutierrez M, Francisco GE, Zhou P, Zhang Y, Li S.
    Toxins (Basel); 2020 Jul 31; 12(8):. PubMed ID: 32751970
    [Abstract] [Full Text] [Related]

  • 32. Long-term effect of additional rehabilitation following botulinum toxin-A on upper limb activity in chronic stroke: the InTENSE randomised trial.
    Lannin NA, Ada L, English C, Ratcliffe J, Faux S, Palit M, Gonzalez S, Olver J, Schneider E, Crotty M, Cameron ID.
    BMC Neurol; 2022 Apr 25; 22(1):154. PubMed ID: 35468766
    [Abstract] [Full Text] [Related]

  • 33. Poststroke Postural Sway Improved by Botulinum Toxin: A Multicenter Randomized Double-blind Controlled Trial.
    Kerzoncuf M, Viton JM, Pellas F, Cotinat M, Calmels P, Milhe de Bovis V, Delarque A, Bensoussan L.
    Arch Phys Med Rehabil; 2020 Feb 25; 101(2):242-248. PubMed ID: 31469982
    [Abstract] [Full Text] [Related]

  • 34. Validity and reliability of the chronic composite XA, an upper limb motor assessment using Active Range of Motion in patients with chronic stroke.
    Jamal K, Butet S, Maitre B, Gracies JM, Hameau S, Leveque LE Bras É, Baude M, Cordillet S, Bonan I.
    Eur J Phys Rehabil Med; 2024 Aug 25; 60(4):559-566. PubMed ID: 38958692
    [Abstract] [Full Text] [Related]

  • 35. Constraint-Induced Movement Therapy After Injection of Botulinum Toxin Type A for a Patient With Chronic Stroke: One-Year Follow-up Case Report.
    Amano S, Takebayashi T, Hanada K, Umeji A, Marumoto K, Furukawa K, Domen K.
    Phys Ther; 2015 Jul 25; 95(7):1039-45. PubMed ID: 25592185
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Efficacy and Safety of AbobotulinumtoxinA (Dysport) for the Treatment of Hemiparesis in Adults With Upper Limb Spasticity Previously Treated With Botulinum Toxin: Subanalysis From a Phase 3 Randomized Controlled Trial.
    Marciniak C, McAllister P, Walker H, Brashear A, Edgley S, Deltombe T, Khatkova S, Banach M, Gul F, Vilain C, Picaut P, Grandoulier AS, Gracies JM, International AbobotulinumtoxinA Adult Upper Limb Spasticity Study Group.
    PM R; 2017 Dec 25; 9(12):1181-1190. PubMed ID: 28625615
    [Abstract] [Full Text] [Related]

  • 38. Effects of repetitive facilitative exercise with neuromuscular electrical stimulation, vibratory stimulation and repetitive transcranial magnetic stimulation of the hemiplegic hand in chronic stroke patients.
    Etoh S, Noma T, Takiyoshi Y, Arima M, Ohama R, Yokoyama K, Hokazono A, Amano Y, Shimodozono M, Kawahira K.
    Int J Neurosci; 2016 Nov 25; 126(11):1007-12. PubMed ID: 26473535
    [Abstract] [Full Text] [Related]

  • 39. [Impact of integrated upper limb spasticity management including repeat botulinum toxin type A (BoNT-A) injections on patient-centred goal attainment in real-life practice: results from the prospective, observational Upper Limb International Spasticity cohort study (ULIS-III) in a Russian subpopulation].
    Khat'kova SE, Baikova A, Maisonobe P, Khasanova DR.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021 Nov 25; 121(11):39-48. PubMed ID: 34932284
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.